The Human Genome: RNA Machine

The Human Genome: RNA Machine Contrary to current dogma, most of the genome may be functional. John S. Mattick Related Articles 1 The idea of "junk DNA" is also based on the assumption that most genetic information is transacted via proteins, an assumption that dates back half a century to a time when the pioneers of molecular biology were studying bacteria, wherein most genes do indeed encode proteins. By contrast, protein coding sequences occupy only ~1.2% of the

Written byJohn S. Mattick
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

John S. Mattick

1 The idea of "junk DNA" is also based on the assumption that most genetic information is transacted via proteins, an assumption that dates back half a century to a time when the pioneers of molecular biology were studying bacteria, wherein most genes do indeed encode proteins. By contrast, protein coding sequences occupy only ~1.2% of the human genome.

When introns were discovered 30 years ago it was immediately and universally assumed that these vast tracts of nonprotein-coding sequences within genes are nonfunctional, despite the fact they are transcribed. Their presence was rationalized as the leftovers of the early evolution of genes.2 At the same time, the finding that much of the mammalian genome (45% in humans) is derived from transposons, which are thought to be mainly parasitic hitchhikers, led to the related concept of "selfish DNA."3,4 This reinforced the increasingly conventional view that the genomes of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies